Two Sigma Advisers’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,692
| Closed | -$1.85M | – | 2731 |
|
|
2021
Q4 | $1.85M | Sell |
4,692
-13,084
| -74% | -$5.16M | ﹤0.01% | 1239 |
|
|
2021
Q3 | $7.96M | Sell |
17,776
-8,232
| -32% | -$3.68M | 0.02% | 586 |
|
|
2021
Q2 | $10.1M | Sell |
26,008
-6,272
| -19% | -$2.44M | 0.03% | 560 |
|
|
2021
Q1 | $11.6M | Buy |
32,280
+4,400
| +16% | +$1.58M | 0.03% | 518 |
|
|
2020
Q4 | $13.7M | Buy |
27,880
+12,208
| +78% | +$5.99M | 0.04% | 457 |
|
|
2020
Q3 | $5.08M | Buy |
15,672
+4,180
| +36% | +$1.35M | 0.01% | 760 |
|
|
2020
Q2 | $4.19M | Buy |
11,492
+1,456
| +15% | +$530K | 0.01% | 870 |
|
|
2020
Q1 | $2.14M | Buy |
10,036
+2,000
| +25% | +$425K | 0.01% | 1085 |
|
|
2019
Q4 | $3.31M | Buy |
8,036
+5,408
| +206% | +$2.23M | 0.01% | 1003 |
|
|
2019
Q3 | $928K | Buy |
+2,628
| New | +$928K | ﹤0.01% | 1476 |
|
|
2018
Q3 | – | Sell |
-392
| Closed | -$360K | – | 2227 |
|
|
2018
Q2 | $360K | Buy |
+392
| New | +$360K | ﹤0.01% | 2038 |
|